T‐Cell Receptor Repertoires Show Dynamic Variation Between Diagnosis and Relapse of Diffuse Large B‐Cell Lymphoma

Documenti analoghi

• Dynamic Profiling of Cell Free Tumour DNA in Aggressive B‐Cell Lymphoma From Diagnosis to Transformation at Relapse
  di: Mark Waltham, et al.
  Pubblicazione: (2025)
• Allogeneic Hematopoietic Cell Transplantation for Relapsed or Refractory Mantle Cell Lymphoma: Real‐World Outcomes, Late Relapse Patterns, and Clinical Utility in the Chimeric Antigen Receptor T‐Cell Era
  di: Enver Aydilek, et al.
  Pubblicazione: (2026)
• A Real‐World Study of Tafasitamab for the Treatment of Relapsed or Refractory Diffuse Large B‐Cell Lymphoma in the United States
  di: Kim Saverno, et al.
  Pubblicazione: (2026)
• Ocular Involvement of Relapsed Nodal T Follicular Helper Cell Lymphoma, Angioimmunoblastic Type
  di: Seiya Bamba, et al.
  Pubblicazione: (2026)
• A Pilot Collaborative Study to Improve the Diagnosis and Treatment of Patients With Newly Diagnosed Diffuse Large B‐Cell Lymphoma in Senegal: The LYMPHODAK Study
  di: Saliou Diop, et al.
  Pubblicazione: (2025)